Deborah Brown
Director/Board Member at ONCOLYTICS BIOTECH INC.
Net worth: 185 348 $ as of 30/04/2024
Profile
Deborah M.
Brown is an Independent Director at Oncolytics Biotech, Inc., Director at Life Sciences Ontario, Director & Managing Partner at Accelera Canada Ltd., and Director at Hamilton Burlington Spca.
She was formerly the Chairman at Innovative Medicines Canada, Independent Director at Sernova Corp., Independent Director at Cardiol Therapeutics, Inc., Director at BIOTECanada, Executive Vice President-US Neuroimmunology at EMD Serono, Inc., and Manager-International Regulatory at Pasteur Mérieux Connaught.
Brown holds an undergraduate degree from the University of Guelph and an MBA from the Richard Ivey School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0.15% | 07/03/2024 | 114,211 ( 0.15% ) | 123 348 $ | 30/04/2024 |
SERNOVA CORP.
0.07% | 25/04/2023 | 200,000 ( 0.07% ) | 62 000 $ | 30/04/2024 |
Deborah Brown active positions
| Companies | Position | Start |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Director/Board Member | 02/11/2017 |
Accelera Canada Ltd.
 Accelera Canada Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market. | Director/Board Member | - |
| Life Sciences Ontario | Director/Board Member | - |
| Hamilton Burlington Spca | Director/Board Member | - |
Former positions of Deborah Brown
| Companies | Position | End |
|---|---|---|
| SERNOVA CORP. | Director/Board Member | 30/05/2023 |
| CARDIOL THERAPEUTICS INC. | Director/Board Member | 07/09/2021 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Chairman | 01/01/2014 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2014 |
| EMD Serono Canada, Inc. | Sales & Marketing | - |
Training of Deborah Brown
| University of Guelph | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ONCOLYTICS BIOTECH INC. | Health Technology |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| SERNOVA CORP. | Health Technology |
| Private companies | 8 |
|---|---|
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
Accelera Canada Ltd.
Accelera Canada Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market. | Commercial Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Life Sciences Ontario | |
| Hamilton Burlington Spca | |
| Pasteur Mérieux Connaught | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
| EMD Serono Canada, Inc. |
- Stock Market
- Insiders
- Deborah Brown
